Ranbaxy recalls drugs for skin disease from US market

Pharma major Ranbaxy Laboratories today said its US-based subsidiary, Ranbaxy Laboratories Inc Priceton NJ, is recalling capsules used in the treatment of acne (a type of skin disease) from the US market. (Source: The Economic Times Healthcare and Biotech News)

See the original post:
Ranbaxy recalls drugs for skin disease from US market

Related posts:

1. Ranbaxy recalls drug in US Ranbaxy Laboratories is voluntarily recalling a batch of its best-selling...
2. Ranbaxy recalls over 4,000 cartons of acne drug in US Ranbaxy Laboratories has initiated a voluntary recall of 4,348 cartons...
3. Treatment Options For Acne Patients Post Accutane’s Withdrawal From US Market Roche Holding AG, the world's biggest maker of cancer drugs,...
4. How Drug For Leukemia, Psoriasis, May Tackle Vascular Disease A drug that has been on the market for decades...
5. Innocent parties or devious drug users: the views of primary healthcare practitioners with respect to those who misuse prescription drugs Conclusions: A binary view of PDM may not be helpful...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message